Fact CheckerSign in

NCT06664073Not yet recruiting

Heart Risk 6 Scale in Emergency Department Acute Heart Failure Patients

The Predictive Value of the HEARTRISK6 Scale in Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients

Source: ClinicalTrials.gov · Last updated 29 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Detect the predictive value of the HEARTRISK6 Scale in Predicting Short-Term Serious Outcomes in emergency department acute heart failure patients in Egyptian population

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
125 (estimated)
First submitted
27 Oct 2024
Start date
27 Oct 2024
Primary completion date
27 Oct 2025
Lead sponsor
Assiut University
NCT number
NCT06664073

What you commit to

  • Study type: Observational
  • Planned participants: 125
  • From 27 Oct 2024 to the primary completion date, 27 Oct 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients who did not fit the definition of AHF or who were clearly too ill to be considered for discharge after 24 hours from ED:
    • 1\) resting oxygen saturation \<85% on room air
    • 2\) heart rate \>120 beats/min;
    • 3\) systolic blood pressure \<85 mm Hg;
    • 4\) confusion, disorientation, dementia;
    • 5\) primary presentation for ischemic chest pain requiring treatment or with acute ischemic ST-Tchanges on initial electrocardiogram (ECG);

Who the study is looking for

  • patients who have appropriate symptoms (short-ness of breath or fatigue)(\<7 days duration); with clinical signs of fluid retention (pulmonary or peripheral) in the presence of an underlying abnormality of cardiac structure or function.
    • If in doubt, a beneficial response to treatment (eg, a brisk diuresis accompanied by improvement in breathlessness) will be considered.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.